Cancer Neuroscience is a rapidly growing interdisciplinary field that focuses on the link between the nervous system and cancer.

Increasing evidence recognizes the essential role of the neoaxonogenesis in the onset, progression, and metastasis of cancer, establishing it as a novel component of the tumor microenvironment. Conversely, treatments for cancer can damage the nervous system, causing neuropathy that reduces quality of life among cancer survivors. Scholarly articles mentioning “cancer” AND “neuroscience” have witnessed an increase from 216 articles in 2000 to 4,852 in 2023. 

The aim of this symposium is to fortify existing and initiate new connections among researchers across our unique tri-campus ecosystem, interested in the emerging field of Cancer Neuroscience.

This symposium is hosted by Temple Innovation Nest (iNest) and sponsored by Evident.

Scientific Chair: Bojana Gligorijevic, PhD, Temple Bioengineering

Keynote and Speakers: 8:30 a.m. - 12:00 p.m.

Lunch and Panel: 12:00 p.m. - 2:00 p.m.

Keynote: John S. Condeelis, PhD, Albert Einstein College of Medicine, NYC

Speakers: Bojana Gligorijevic, PhD, Temple University Bioengineering, Sylvie Deborde, PhD, Memorial Sloan Kettering, Jorge Gómez Deza, MRes, PhD, Lewis Katz School of Medicine, Qing Chen, MD, PhD, Fox Chase Cancer Center, Eti Cukierman, PhD, Fox Chase Cancer Center, Anjali Rajadhyaksha, PhD, Lewis Katz School of Medicine

Foundation Panel: American Cancer Society (ACS), Concern Foundation, American Association for Cancer Research (AACR), METAvivor